Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311)
暂无分享，去创建一个
W. A. Tellez | S. Chawla | E. Gordon | Ania Moradkhani | V. Chua-Alcala | D. Quon | Hripsime Chomoyan | Chrysler Valencia | D. Brigham | Nadezhda Omelchenko | A. Ahari | Stefan Makrievski | N. Omelchenko | S. Makrievski